Work

PU.1: C/EBPα ratio-directed reprogramming converts B-ALL cells into stable M1 macrophages for scalable cancer immunotherapy

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-4133

Authors: Mengjie Li, Tianshuo Song, Zhiling Shi, Jiazhuo Li, Thomas Graf, Huafeng Xie

Institutions: South China University of Technology, Guangzhou First People's Hospital, Barcelona Institute of Science and Technology, Centre for Genomic Regulation

Language: English

Topic: Immune cells in cancer

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417022206

Cites:

Cited by:

Related to: